Literature DB >> 15327565

Psoriatic lesions induced by antitumour necrosis factor-alpha treatment: two cases.

O Dereure, B Guillot, C Jorgensen, J-D Cohen, B Combes, J-J Guilhou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15327565     DOI： 10.1111/j.1365-2133.2004.06107.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  9 in total

1.  New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists.

Authors:  S Kary; M Worm; H Audring; D Huscher; M Renelt; H Sörensen; E Ständer; U Maass; H Lee; W Sterry; G-R Burmester
Journal:  Ann Rheum Dis       Date:  2005-09-08       Impact factor: 19.103

2.  Psoriasis after treatment of juvenile idiopathic arthritis with etanercept.

Authors:  R Peek; R Scott-Jupp; H Strike; J Clinch; A V Ramanan
Journal:  Ann Rheum Dis       Date:  2006-09       Impact factor: 19.103

3.  Psoriasis onset during infliximab treatment: description of two cases.

Authors:  Alessandro Volpe; Paola Caramaschi; Antonio Carletto; Sara Pieropan; Lisa Maria Bambara; Domenico Biasi
Journal:  Rheumatol Int       Date:  2006-10       Impact factor: 2.631

Review 4.  TNF receptor 2 pathway: drug target for autoimmune diseases.

Authors:  Denise Faustman; Miriam Davis
Journal:  Nat Rev Drug Discov       Date:  2010-05-21       Impact factor: 84.694

Review 5.  Chimeric fusion proteins used for therapy: indications, mechanisms, and safety.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.228

Review 6.  Pathogenesis of Paradoxical Reactions Associated with Targeted Biologic Agents for Inflammatory Skin Diseases.

Authors:  Fumi Miyagawa
Journal:  Biomedicines       Date:  2022-06-23

7.  The changing face of spondyloarthropathies under TNF α blockade.

Authors:  Ori Elkayam; Irena Litinsky; David Levartovsky; Dan Caspi
Journal:  Open Rheumatol J       Date:  2008-11-14

8.  Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.

Authors:  M J Harrison; W G Dixon; K D Watson; Y King; R Groves; K L Hyrich; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2008-04-02       Impact factor: 19.103

9.  Paradoxical Psoriasis Induced by Anti-TNFα Treatment: Evaluation of Disease-Specific Clinical and Genetic Markers.

Authors:  Agostino Bucalo; Federica Rega; Arianna Zangrilli; Valentina Silvestri; Virginia Valentini; Giorgia Scafetta; Federica Marraffa; Sara Grassi; Elena Rogante; Arianna Piccolo; Salvatore Cucchiara; Franca Viola; Luca Bianchi; Laura Ottini; Antonio Richetta
Journal:  Int J Mol Sci       Date:  2020-10-23       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.